ImmunoGen’s Investigative Therapy for Ovarian Cancer Shows Potential in Clinical Studies
News
ImmunoGen will show promising safety and efficacy data of its investigative treatment mirvetuximab soravtansine for the treatment of FRα-positive epithelial ovarian cancer (EOC). The ... Read more